CHANGMAO BIO Maintains Stable Share Structure in June; Public Float Remains Compliant

Bulletin Express
Jul 02

Hong Kong—Changmao Biochemical Engineering Company Limited (CHANGMAO BIO) filed its monthly return for the period ended 30 June 2026, confirming a stable capital base and full compliance with Hong Kong Stock Exchange (HKEX) public-float requirements.

Key highlights:

1. Authorised and Registered Capital • Ordinary H shares: 183.70 million shares at RMB 0.10 par value, representing RMB 18.37 million of authorised capital—unchanged from May 2026. • Domestic shares: 2.50 million shares at RMB 0.10, equal to RMB 0.25 million—unchanged. • Foreign shares: 343.50 million shares at RMB 0.10, equal to RMB 34.35 million—unchanged. Total authorised capital across all classes remained RMB 52.97 million.

2. Issued Share Capital and Treasury Position • Listed H shares in issue: 183.70 million; no treasury shares were held or cancelled during the month. • Unlisted domestic shares: 2.50 million, unchanged. • Unlisted foreign shares: 343.50 million, unchanged. No movements occurred in any class—no new issuance, repurchase, or cancellations.

3. Public Float Compliance The company confirmed that at 30 June 2026 it satisfied the HKEX minimum public-float threshold of 25% for its H shares.

4. Capital Instruments and Corporate Actions • No share option grants, exercises, lapses, or cancellations. • No warrants, convertibles, or other equity-linked instruments outstanding or exercised. • No other share issuance agreements, redemptions, or treasury-share transactions were reported.

The filing, signed by Company Secretary Ms. Wan Pui Ling Alice, affirms adherence to all applicable listing rules and regulatory requirements during the reporting month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10